Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 302 for “"cachexia"”.
-
Role of Sex Differences on Cancer Cachexia Progression and Fibrosis during Cancer Cachexia Development
Cancer cachexia is a multifactorial wasting syndrome characterized by losses in bodymass >5% and occurs in approximately 80% of all cancer patients. Chronic inflammation and fibrosis play roles in cancer cachexia and a greater understanding of these contributing pathways to this pathology will pave …
-
Mechanisms of tumour-induced cachexia
The effect of cancer cachexia on host metabolism has been studied in mice transplanted with either the MAC16 adenocarcinoma which induces profound loss of host body weight and depletion of lipid stores or, the MAC13 adenocarcinoma which is of the same histological type, but which grows without an …
-
Catabolic Factors in Tumour-Induced Cachexia
… (MAC16) was utilized as a model of human cancer cachexia. The MAC16 tumour produced extensive weight loss in the host at small tumour burdens and without a reduction in either food or fluid intake. The weight loss was characterised by a decrease in both carcass fat and muscle mass which were …
-
Polyunsaturated fatty acids in tumour-induced cachexia
… (MAC16) was utilised as a model of human cancer cachexia. This tumour has been found to produce extensive weight loss, characterised by depletion of host body protein and lipid stores at a small tumour burden. This weight loss has been found to be associated with production by the tumour of a …
-
Inhibitors of lipolysis in tumor-induced cachexia
… ω-3 PUFA, docosahexaenoic acid (DHA), to inhibit cachexia may be due to a difference in the metabolic fates of these two fatty acids. BW A4C inhibited lipolysis in isolated adipocytes which suggests that this compound may possess the potential for an anti-cachectic effect which is independent of …
-
Phenotypes and genetic markers of cancer cachexia
Cancer cachexia is a chronic wasting syndrome characterised by loss of weight, composed principally of muscle and fat. Patients with advanced cachexia demonstrate loss of appetite, early satiety, severe weight loss, weakness, anaemia and fluid retention. Affected individuals are also likely to …
-
Exploring the mechanistic underpinnings of cancer-induced cachexia.
Cancer cachexia (CC) is described as a multifactorial syndrome of progressive, unintentional weight loss occurring in 30-90% of advanced cancer patients and 80% of metastatic cancer patients. Despite the major burden CC poses on both patient quality of life and life expectancy, knowledge of this …
-
Insulin, metabolism and cancer cachexia in the rat
Bibliography: leaf 152-167.
-
Mechanism of muscle protein degradation in Cancer Cachexia
… weight 24 KDa (p24) was purified both from the cachexia-inducing MAC 16 tumour and the urine of cachectic cancer patients by a combination of ammonium sulphate precipitation and affinity chromatography using a monoclonal antibody developed against the murine material. Administration of p24 to …
-
Purification and characterisation of two cancer cachexia factors
Cachexia is a wasting phenomenon that often accompanies malignant disease. Its manifestation is associated with shortened survival and reduced responsiveness to anti-tumour therapy and as yet there is no established, effective amelioratory treatment. The MAC 16 model of cancer cachexia has been …
-
RNA Sequencing in the Development of Cancer-Cachexia
… 1,660,290 new cases of cancer in the U.S. Cancer-Cachexia (CC) is a common effect of many cancers, and is directly responsible for 20-40% of cancer-related deaths. The mechanisms that control the development of CC are not well understood. Most investigations of CC focus on the post-cachectic state …
-
An Integrated Skeletal Muscle Methylome-transcriptome Profile in Pre-clinical Colorectal Cancer Cachexia Models and Chemotherapy Aggravating the Effects of Cachexia
Cancer cachexia is a wasting syndrome characterized by the loss of skeletal muscle affecting cancer patients’ independence and quality of life. Cancer cachexia affects up to 80% of cancer patients and is responsible for 30-40% of cancer-related deaths. Previous studies have demonstrated …
-
The IRE1α/XBP1 Signaling in Regenerative Myogenesis and Cachexia
… leads to skeletal muscle wasting during cancer cachexia.
-
Musculoskeletal Effects of Oncostatin M in Pancreatic Cancer Cachexia
… to muscle and fat wasting, is characteristic of cachexia. Understanding the molecular mechanisms that drive malignant inflammation is critical to improve PDAC therapy and increase patient survival. Oncostatin M (OSM) belongs to the IL-6/GP130 family of cytokines, members of which have been shown …
-
GDF11 mediates cardiac and skeletal muscle dysfunction and cachexia
Growth differentiation factor 11 (GDF11) is important in regulating early fetal development of the axial skeleton and various visceral organs. Its actions on the adult body are less clear, and recent studies have led to conflicting accounts of GDF11’s ability to affect cardiac hypertrophy and …
-
Cancer Heterogeneity and Mitochondrial-Targeted Therapies in Cancer Cachexia
Cancer Cachexia (CC) is a multifactorial and complex syndrome affecting up to 80% of cancer patients and contributing to approximately 40% of cancer-related deaths. Given its relationship with patients' quality of life and prognosis, there has been increasing emphasis on understanding the …
Page 1 of 16